Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

Université de Sherbrooke

$25,000.00

Synthesis of a diversified boron reagent library for drug development

EF 2017-18

Résumé
The health sector is facing numerous challenges. For example, the emergence of multidrug-resistant pathogensrequires the development of new antibiotic drugs to protect the population. In this context, organic synthesisplays a vital role. Indeed, the development of new synthetic methods and reagents for the creation andevaluation of new molecules of biological interest is the foundation on which we improve the drugs availableto treat illnesses. Consequently, there is a need to expand the pool of reagents available supporting drugdevelopment. One strategy is to use libraries of high-value building blocks reagents that enable rapid creationof complex and diverse molecules.Intellisyn is thus looking to acquire a diversified collection of highly-functionalized organotrifluoroborate saltsand boronic acids, which will greatly expand their reagents library. The goal of this project is to create suchlibrary, using reagents recently developed in our group. This will greatly expand the reagents library ofIntellisyn. The compounds furnished through this project are not available commercially and will greatlyfacilitate their drug development pipeline. It will consequently contribute to their competitiveness andexpansion in Canada. In addition, this project will enable the development of new arylation methods that willbe useful in the field of organic synthesis.
Programme
Engage Grants Program
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
520481-2017
Name nom
Legault, Claude
Department département
Chimie
Organization id
68
Institution établissement
Université de Sherbrooke
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2017
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1552
Committee name en
Quebec Internal Decision Committee
Committee name fr
Comité de décision interne pour le Québec
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3703
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Organic syntheses
Research subject fr
Synthèses organiques
Partie
1
Nb partie
1
Application title
Synthesis of a diversified boron reagent library for drug development
Keyword
NSERC
Application summary
The health sector is facing numerous challenges. For example, the emergence of multidrug-resistant pathogensrequires the development of new antibiotic drugs to protect the population. In this context, organic synthesisplays a vital role. Indeed, the development of new synthetic methods and reagents for the creation andevaluation of new molecules of biological interest is the foundation on which we improve the drugs availableto treat illnesses. Consequently, there is a need to expand the pool of reagents available supporting drugdevelopment. One strategy is to use libraries of high-value building blocks reagents that enable rapid creationof complex and diverse molecules.Intellisyn is thus looking to acquire a diversified collection of highly-functionalized organotrifluoroborate saltsand boronic acids, which will greatly expand their reagents library. The goal of this project is to create suchlibrary, using reagents recently developed in our group. This will greatly expand the reagents library ofIntellisyn. The compounds furnished through this project are not available commercially and will greatlyfacilitate their drug development pipeline. It will consequently contribute to their competitiveness andexpansion in Canada. In addition, this project will enable the development of new arylation methods that willbe useful in the field of organic synthesis.